Brief: Deciphera Pharmaceuticals Announces Appointment Of Dashyant Dhanak, Ph.D., As Executive Vice President
03/08/2023 21:39
Aug 3 (Reuters) - Deciphera Pharmaceuticals Inc
DCPH.O :
* DECIPHERA PHARMACEUTICALS ANNOUNCES RETIREMENT OF DANIEL
L.
FLYNN, PH.D., AND APPOINTMENT OF DASHYANT DHANAK, PH.D., AS
EXECUTIVE VICE PRESIDENT AND CHIEF SCIENTIFIC OFFICER
Source text for Eikon: ID:nBwVhs5Na
Further company coverage: DCPH.O
Recent news on Deciphera Pharmaceuticals
See all newsBrief: Deciphera Pharmaceuticals Announces Oral Presentation Of Results From Phase 3 Study of Vimseltinib In Patients With Tenosynovial Giant Cell Tumor
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Deals of the day-Mergers and acquisitions